加尔西尼亚提取物对糖尿病外围神经病的神经保护潜力:GC-MS分析,网络药理学,分子对接和体外研究
Arpita Paul1,2, Mohit Kumar1,3, Diksheeta Sharma1,4
1Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam 786004 India.
3 Biotech
|November 24, 2025
概括
来自Garcinia pedunculata (MEGP) 和Garcinia lanceifolia (MEGL) 的甲醇提取物显示出对糖尿病外围神经病变 (DPN) 的显著神经保护作用. 这些天然化合物针对关键路径,为DPN治疗提供了有前途的多目标干预.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 化学信息学 化学信息学
背景情况:
- 糖尿病外围神经病变 (DPN) 具有挑战性,难以用单一向药物治疗.
- 有效的DPN药物治疗需要多个目标干预措施.
研究的目的:
- 研究Garcinia pedunculata (MEGP) 和Garcinia lanceifolia (MEGL) 中的甲醇果实提取物对DPN的神经保护潜力.
- 用集成的计算和实验方法阐明底层的多目标机制.
主要方法:
- 气色谱-质谱 (GC-MS) 用于化合物分析.
- 化学信息学和系统药理学用于目标预测和网络分析.
- 分子对接以评估结合亲缘关系.
- 在体外基于细胞的测定使用高葡萄糖压力SH-SY5Y细胞.
主要成果:
- 在MEGP和MEGL中确定了生物活性化合物,预测目标和DPN相关基因之间有显著的重叠.
- 网络分析强调TNF和AKT1是关键的枢纽,涉及PI3K-Akt,MAPK,JAK-STAT和Wnt/β-catenin通路.
- 分子对接显示了特定化合物与AKT1和TNF的良好结合.
- 实验室研究表明,在MEGP和MEGL前期治疗时,显著的细胞保护,减少ROS和减少亡,MEGP显示出更高的疗效.
结论:
- MEGP和MEGL通过TNF和AKT1中心的信号网络对DPN表现出多目标的神经保护作用.
- 这些提取物显示出DPN治疗的多药学潜力.
- 重点是保护这些临灭绝的生物活性丰富物种.
更多相关视频
相关概念视频
Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


